Dr. Kesler is a cognitive neuroscientist with specific expertise in neuroimaging, neuropsychology, biostatistics, machine learning, and computer programming. Her research program focuses on the neural mechanisms of chronic conditions, especially cancer-related cognitive neurotoxicities. Her work includes both clinical and preclinical studies that focus on translational approaches for measuring the functional and structural connectome in both humans and animals using MR neuroimaging. The overarching goals of her work concern the neurobiologic subtyping of cognitive impairments as well as neuroimaging-based prediction of cognitive-behavioral outcomes, survival and treatment response across the lifespan. She has obtained over $14 million in external grant funding including four NIH R01's and the prestigious NIH Director's New Innovator Award.